Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem has informed the stock exchanges that its trading window will be closed starting Tuesday, 1 July 2025. The window will remain shut for all designated persons and their immediate relatives until 48 hours after the company declares its unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26). This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015, and the company's own insider trading code. Designated persons have been barred from trading in the company's shares during this period.
This is a routine regulatory disclosure and not an operational update. The closure period typically signals that the Q1 FY26 earnings announcement is likely due sometime in July or early August 2025. No direct impact on shareholders' holdings or stock price is expected from this intimation itself.